Equilibrium and kinetic analysis of human interleukin-13 and IL-13 receptor alpha-2 complex formation

Journal of Molecular Recognition

Volumn 25, Issue 3, 2012, Pages 184-191

  Lacy, Eilyn R ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

asthma; Biacore; cytokine; IL 13; IL 13 R110Q; IL 13R 2; kinetic exclusion assay; SPR

Indexed keywords

EID: 84858234083     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.2150     Document Type: Article

References (39)

1. Abdiche YN, Malashock DS, Pons J,. 2008. Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors. Protein Sci. 17 (8): 1326-35.
2. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ,. 1996. cDNA cloning and characterization of the human interleukin 13 receptor Î ± chain. J. Biol. Chem. 271 (46): 29265-29270. (Pubitemid 26382639)
3. Andrews A-L, Bucchieri F, Arima K, Izuhara K, Holgate ST, Davies DE, Holloway JW,. 2007. Effect of IL-13 receptor α2 levels on the biological activity of IL-13 variant R110Q. J. Allergy Clin. Immunol. 120 (1): 91-97. (Pubitemid 46990508)
4. Andrews A-L, Holloway JW, Puddicombe SM, Holgate ST, Davies DE,. 2002. Kinetic analysis of the interleukin-13 receptor complex. J. Biol. Chem. 277 (48): 46073-46078. (Pubitemid 35417594)
5. Arima K, Umeshita-Suyama R, Sakata Y, Akaiwa M, Mao X-Q, Enomoto T, Dake Y, Shimazu S-i, Yamashita T, Sugawara N, Brodeur S, Geha R, Puri RK, Sayegh MH, Adra CN, Hamasaki N, Hopkin JM, Shirakawa T, Izuhara K,. 2002. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J. Allergy Clin. Immunol. 109 (6): 980-987. (Pubitemid 34634309)
6. Black S, Teixeira AS, Loh AXW, Vinall L, Holloway JW, Hardy R, Swallow DM,. 2009. Contribution of functional variation in the IL13 gene to allergy, hay fever and asthma in the NSHD longitudinal 1946 birth cohort. Allergy 64 (8): 1172-1178.
7. Caput D, Laurent P, Kaghad M, Lelias J-M, Lefort S, Vita N, Ferrara P,. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J. Biol. Chem. 271 (28): 16921-16926. (Pubitemid 26239062)
8. Chen W, Sivaprasad U, Tabata Y, Gibson AM, Stier MT, Finkelman FD, Hershey GKK,. 2009. IL-13Rα2 membrane and soluble isoforms differ in humans and mice. J. Immunol. 183 (12): 7870-7876.
9. Daines MO, Chen W, Tabata Y, Walker BA, Gibson AM, Masino JA, Warrier MR, Daines CL, Wenzel SE, Hershey GKK,. 2007. Allergen-dependent solubilization of IL-13 receptor [alpha]2 reveals a novel mechanism to regulate allergy. J. Allergy Clin. Immunol. 119 (2): 375-383. (Pubitemid 46204800)
10. Darling RJ, Brault PA,. 2004. Kinetic exclusion assay technology: characterization of molecular interactions. Assay Drug Dev. Technol. 2 (6): 647-57. (Pubitemid 40309424)
11. Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, O'Hara RM, Jr., Beier DR, Turner KJ, Wood CR, Collins M,. 1998. The murine IL-13 receptor α 2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J. Immunol. 161 (5): 2317-2324. (Pubitemid 28397044)
12. Drake AW, Myszka DG, Klakamp SL,. 2004. Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods. Anal. Biochem. 328 (1): 35-43. (Pubitemid 38479615)
13. Fichtner-Feigl S, Fuss IJ, Young CA, Watanabe T, Geissler EK, Schlitt H-J, Kitani A, Strober W,. 2007. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J. Immunol. 178 (9): 5859-5870. (Pubitemid 46674383)
14. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A,. 2006. IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-[beta]1 production and fibrosis. Nat. Med. 12 (1): 99-106. (Pubitemid 43050083)
15. Fichtner-Feigl S, Young CA, Kitani A, Geissler EK, Schlitt H-J, Strober W,. 2008. IL-13 signaling via IL-13R[alpha]2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 135 (6): 2003-2013.e7.
16. Granel B, Allanore Y, Chevillard C, Arnaud V, Marquet S, Weiller P-J, Durand J-M, Harlé J-R, Grange C, Frances Y, Berbis P, Gaudart J, de Micco P, Kahan A, Dessein A,. 2006. IL13RA2 gene polymorphisms are associated with systemic sclerosis. J. Rheumatol. 33 (10): 2015-2019. (Pubitemid 44571875)
17. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, Ohshima K, Umeshita R, Abe Y, Braun S, Yamashita T, Roberts MH, Sugimoto R, Arima K, Arinobu Y, Yu B, Kruse S, Enomoto T, Dake Y, Kawai M, Shimazu S, Sasaki S, Adra CN, Kitaichi M, Inoue H, Yamauchi K, Tomichi N, Kurimoto F, Hamasaki N, Hopkin JM, Izuhara K, Shirakawa T, Deichmann KA,. 2000. Genetic variants of IL-13 signalling and human asthma and atopy. Hum. Mol. Genet. 9 (4): 549-559. (Pubitemid 30154013)
18. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA,. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. U. S. A. 93 (1): 497-501. (Pubitemid 26038184)
19. Johnsson B, Lofas S, Lindquist G,. 1991. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198 (2): 268-77.
20. Jonsson U, Fagerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundh K, Lofas S, Persson B, Roos H, Ronnberg I, Sjolander S, Stenberg E, Stahlberg R, Urbaniczky C, Ostlin H, Malmqvist M,. 1991. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11 (5): 620-7.
21. Kawakami K, Taguchi J, Murata T, Puri RK,. 2001. The interleukin-13 receptor {alpha}2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 97 (9): 2673-2679.
22. Kioi M, Seetharam S, Puri RK,. 2006. N-linked glycosylation of IL-13Rα2 is essential for optimal IL-13 inhibitory activity. FASEB J. 20 (13): 2378-2380.
23. MacDonald TT,. 2006. Decoy receptor springs to life and eases fibrosis. Nat. Med. 12 (1): 13-14. (Pubitemid 43050042)
24. McKenzie AN, Culpepper JA, de Waal Malefyt R, Brière F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S,. 1993. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function PNAS 90 (8): 3735-3739. (Pubitemid 23111442)
25. Mentink-Kane MM, Cheever AW, Thompson RW, Hari DM, Kabatereine NB, Vennervald BJ, Ouma JH, Mwatha JK, Jones FM, Donaldson DD, et al. 2004. IL-13 receptor α 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc. Natl. Acad. Sci. U. S. A. 101 (2): 586-590. (Pubitemid 38084680)
26. Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N, Ferrara P,. 1997. Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4R[alpha] of a functional IL-4/IL-13 receptor complex. FEBS Lett. 401 (2-3): 163-166. (Pubitemid 27056108)
27. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D,. 1993. lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362 (6417): 248-250. (Pubitemid 23093630)
28. Myszka DG,. 1999. Improving biosensor analysis. J. Mol. Recognit. 12 (5): 279-84. (Pubitemid 129708590)
29. Ohkuri T, Takeda C, Yoshida Y, Izuhara K, Imoto T, Ueda T,. 2007. Expression of human IL-13 receptor α 2 extracellular domain in Pichia pastoris. Protein Expr. Purif. 56 (1): 48-53. (Pubitemid 47499084)
30. Palikhe NS, Kim S-H, Cho B-Y, Choi G-S, Kim J-H, Ye Y-M, Park H-S,. 2010. IL-13 gene polymorphisms are associated with rhinosinusitis and eosinophilic inflammation in aspirin intolerant asthma. Allergy Asthma Immunol Res. 2 (2): 134-140.
31. Rich RL, Papalia GA, Flynn PJ, Furneisen J, Quinn J, Klein JS, Katsamba PS, Waddell MB, Scott M, Thompson J, Berlier J, Corry S, Baltzinger M, Zeder-Lutz G, Schoenemann A, Clabbers A, Wieckowski S, Murphy MM, Page P, Ryan TE, Duffner J, Ganguly T, Corbin J, Gautam S, Anderluh G, Bavdek A, Reichmann D, Yadav SP, Hommema E, Pol E, Drake A, Klakamp S, Chapman T, Kernaghan D, Miller K, Schuman J, Lindquist K, Herlihy K, Murphy MB, Bohnsack R, Andrien B, Brandani P, Terwey D, Millican R, Darling RJ, Wang L, Carter Q, Dotzlaf J, Lopez-Sagaseta J, Campbell I, Torreri P, Hoos S, England P, Liu Y, Abdiche Y, Malashock D, Pinkerton A, Wong M, Lafer E, Hinck C, Thompson K, Primo CD, Joyce A, Brooks J, Torta F, Bagge Hagel AB, Krarup J, Pass J, Ferreira M, Shikov S, Mikolajczyk M, Abe Y, Barbato G, Giannetti AM, Krishnamoorthy G, Beusink B, Satpaev D, Tsang T, Fang E, Partridge J, Brohawn S, Horn J, Pritsch O, Obal G, Nilapwar S, Busby B, Gutierrez-Sanchez G, Gupta RD, Canepa S, Witte K, Nikolovska-Coleska Z, Cho YH, D'Agata R, Schlick K, Calvert R, Munoz EM, Hernaiz MJ, Bravman T, Dines M, Yang MH, Puskas A, Boni E, Li J, Wear M, Grinberg A, Baardsnes J, Dolezal O, Gainey M, Anderson H, Peng J, Lewis M, Spies P, Trinh Q, Bibikov S, Raymond J, Yousef M, Chandrasekaran V, Feng Y, Emerick A, Mundodo S, Guimaraes R, McGirr K, Li YJ, Hughes H, Mantz H, Skrabana R, Witmer M, Ballard J, Martin L, Skladal P, Korza G, Laird-Offringa I, Lee CS, Khadir A, Podlaski F, Neuner P, Rothacker J, Rafique A, Dankbar N, Kainz P, Gedig E, Vuyisich M, Boozer C, Ly N, Toews M, Uren A, Kalyuzhniy O, Lewis K, Chomey E, Pak BJ, Myszka DG,. 2009. A global benchmark study using affinity-based biosensors. Anal. Biochem. 386 (2): 194-216.
32. Teplyakov A, Obmolova G, Wu S-J, Luo J, Kang J, O'Neil K, Gilliland GL,. 2009. Epitope mapping of anti-interleukin-13 neutralizing antibody CNTO607. J. Mol. Biol. 389 (1): 115-123.
33. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D,. 2005. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J. Clin. Invest. 115 (3): 747-754. (Pubitemid 40322251)
34. Wu S-J, Luo J, O'Neil KT, Kang J, Lacy ER, Canziani G, Baker A, Huang M, Tang QM, Raju TS, Jacobs SA, Teplyakov A, Gilliland GL, Feng Y,. 2010. Structure-based engineering of a monoclonal antibody for improved solubility. Protein Eng. Des. Sel. 23 (8): 643-651.
35. Yan X, Su Z, Zhang J, Wu Z, Ye S, Lu X, Wu J, Zeng Y, Zheng W,. 2010. Killing effect of interleukin-13 receptor alpha 2 (IL-13Rα2) sensitized DC-CTL cells on human glioblastoma U251 cells. Cell. Immunol. 263 (2): 172-175.
36. Yoshida Y, Ohkuri T, Takeda C, Kuroki R, Izuhara K, Imoto T, Ueda T,. 2007. Analysis of internal motions of interleukin-13 variant associated with severe bronchial asthma using 15N NMR relaxation measurements. Biochem. Biophys. Res. Commun. 358 (1): 292-297. (Pubitemid 46719115)
37. Zhang J-G, Hilton DJ, Willson TA, McFarlane C, Roberts BA, Moritz RL, Simpson RJ, Alexander WS, Metcalf D, Nicola NA,. 1997. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. J. Biol. Chem. 272 (14): 9474-9480.
38. Zuo L, Fulkerson PC, Finkelman FD, Mingler M, Fischetti CA, Blanchard C, Rothenberg ME,. 2010. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2 inhibited pathway. J. Immunol. 185 (1): 660-669.
39. Zurawski G, de Vries JE,. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15 (1): 19-26.